LU88343I2 - Terbinafine sous toutes les formes y compris ses seis tel que le chlorhydrate - Google Patents
Terbinafine sous toutes les formes y compris ses seis tel que le chlorhydrateInfo
- Publication number
- LU88343I2 LU88343I2 LU88343C LU88343C LU88343I2 LU 88343 I2 LU88343 I2 LU 88343I2 LU 88343 C LU88343 C LU 88343C LU 88343 C LU88343 C LU 88343C LU 88343 I2 LU88343 I2 LU 88343I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- formula
- seis
- terbinafine
- hydrochloride
- forms including
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title 1
- 229960002722 terbinafine Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/04—Acyclic alcohols with carbon-to-carbon triple bonds
- C07C33/048—Acyclic alcohols with carbon-to-carbon triple bonds with double and triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/05—Alcohols containing rings other than six-membered aromatic rings
- C07C33/12—Alcohols containing rings other than six-membered aromatic rings containing five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Replacement Of Web Rolls (AREA)
- Radiation-Therapy Devices (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH765679 | 1979-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU88343I2 true LU88343I2 (fr) | 1994-05-04 |
Family
ID=4328536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU88343C LU88343I2 (fr) | 1979-08-22 | 1993-06-30 | Terbinafine sous toutes les formes y compris ses seis tel que le chlorhydrate |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4755534A (fr) |
| EP (1) | EP0024587B1 (fr) |
| JP (2) | JPS5632440A (fr) |
| AT (1) | ATE10272T1 (fr) |
| AU (1) | AU538928B2 (fr) |
| CA (1) | CA1157023A (fr) |
| CY (1) | CY1410A (fr) |
| DE (3) | DE19975055I1 (fr) |
| DK (1) | DK153470C (fr) |
| ES (1) | ES8105694A1 (fr) |
| FI (1) | FI65775C (fr) |
| HK (1) | HK21588A (fr) |
| IE (1) | IE50878B1 (fr) |
| IL (1) | IL60877A (fr) |
| KE (1) | KE3775A (fr) |
| LU (1) | LU88343I2 (fr) |
| MY (1) | MY8600181A (fr) |
| NL (1) | NL930136I2 (fr) |
| NZ (1) | NZ194714A (fr) |
| PH (1) | PH22166A (fr) |
| PT (1) | PT71717B (fr) |
| SG (1) | SG89287G (fr) |
| YU (1) | YU41513B (fr) |
| ZA (1) | ZA805185B (fr) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132459A (en) * | 1979-08-22 | 1992-07-21 | Sandoz Ltd. | Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
| CH653028A5 (de) * | 1982-02-03 | 1985-12-13 | Sandoz Ag | Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung. |
| FR2526423B1 (fr) * | 1982-05-07 | 1987-07-10 | Sandoz Sa | Nouvelles amines insaturees, leur preparation et leur utilisation comme medicaments |
| JPS6145A (ja) * | 1984-06-09 | 1986-01-06 | Kaken Pharmaceut Co Ltd | Ｎ‐（４‐ｔｅｒｔ‐ブチルベンジル）‐Ｎ‐メチル‐１‐ナフチルメチルアミンおよびそれを有効成分とする抗真菌剤 |
| EP0191269B1 (fr) * | 1984-11-22 | 1991-03-06 | Sandoz Ag | Homopropargylamines |
| CH672311A5 (fr) * | 1985-09-14 | 1989-11-15 | Sandoz Ag | |
| NL8700083A (nl) * | 1986-01-29 | 1987-08-17 | Sandoz Ag | Tegen schimmels werkende aminen, werkwijzen voor de bereiding daarvan en hun toepassing. |
| US4751245A (en) * | 1986-06-25 | 1988-06-14 | E. R. Squibb & Sons, Inc. | Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same |
| EP0254677A1 (fr) * | 1986-07-08 | 1988-01-27 | Sandoz Ag | 6-Phényl-2-hexen-4-ynamines antimycotiques |
| JPS63238060A (ja) * | 1987-03-26 | 1988-10-04 | Maruho Kk | キノリン誘導体 |
| CA1327795C (fr) * | 1987-08-14 | 1994-03-15 | Jules Freedman | Antidepresseurs de type aryloxyindanamines |
| US5149714A (en) * | 1987-08-14 | 1992-09-22 | Merrell Dow Pharmaceuticals Inc. | Antidepressants |
| NZ227042A (en) | 1987-11-27 | 1991-05-28 | Banyu Pharma Co Ltd | Substituted alkylamine derivatives and pharmaceutical compositions |
| US5234946A (en) * | 1987-11-27 | 1993-08-10 | Banyu Pharmaceutical Co., Ltd. | Substituted alkylamine derivatives |
| EP0363326A3 (fr) * | 1988-10-07 | 1991-10-09 | Sandoz Ag | Amines fongicides |
| EP0378457B1 (fr) * | 1989-01-12 | 1994-08-03 | Sumitomo Chemical Company Limited | Composition d'une résine thérmodurcissable à base d'une amine allylique aromatique |
| JP3116364B2 (ja) * | 1989-10-02 | 2000-12-11 | 萬有製薬株式会社 | エンイン誘導体の製造法 |
| FR2673537B1 (fr) * | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
| HU219480B (hu) | 1991-05-23 | 2001-04-28 | Novartis Ag. | Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására |
| GB9111611D0 (en) * | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| JPH04138020U (ja) * | 1991-06-14 | 1992-12-24 | 日立機材株式会社 | バケツトエレベータ |
| GB9513750D0 (en) * | 1995-07-06 | 1995-09-06 | Sandoz Ltd | Use of allylamines |
| NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
| US6075056A (en) * | 1997-10-03 | 2000-06-13 | Penederm, Inc. | Antifungal/steroid topical compositions |
| SK5202000A3 (en) | 2000-04-07 | 2001-12-03 | Slovakofarma As | Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4- inyl)-n-methyl-1-naphthalenemethylamine (terbinaphin) |
| IL152696A0 (en) * | 2000-06-09 | 2003-06-24 | Bayer Cropscience Sa | Process for the preparation of pesticidal compounds |
| IL137364A (en) * | 2000-07-18 | 2005-08-31 | Chemagis Ltd | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol |
| GB0103046D0 (en) | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
| US7244703B2 (en) * | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
| KR100459275B1 (ko) | 2001-12-28 | 2004-12-03 | 주식회사유한양행 | 터비나핀 또는 그의 염산염의 제조방법 |
| BG65097B1 (bg) * | 2002-03-15 | 2007-02-28 | Richter Gedeon Vegyeszeti Gyar Rt. | Метод за получаване на заместено производно на алиламин и на съответните му соли |
| RU2207124C1 (ru) * | 2002-04-24 | 2003-06-27 | Закрытое акционерное общество "Брынцалов-А" | Крем "брамизил" противогрибкового действия |
| US8404751B2 (en) | 2002-09-27 | 2013-03-26 | Hallux, Inc. | Subunguicide, and method for treating onychomycosis |
| WO2004084826A2 (fr) | 2003-03-21 | 2004-10-07 | Nexmed Holdings, Inc. | Enduit a ongles antifongique et procede d'utilisation |
| GB0320312D0 (en) * | 2003-08-29 | 2003-10-01 | Novartis Ag | Purification process |
| GB0503942D0 (en) * | 2005-02-25 | 2005-04-06 | Novartis Ag | Purification process |
| US20050197512A1 (en) * | 2003-08-29 | 2005-09-08 | Ulrich Beutler | Purification process |
| CN101829319A (zh) * | 2003-12-08 | 2010-09-15 | Cpex药品公司 | 用于胰岛素治疗的药用组合物及方法 |
| ES2245596B1 (es) * | 2004-06-10 | 2007-07-01 | Ercros Industrial, S.A. | Procedimiento para la obtencion de clorhidrato de terbinafina. |
| US20060004230A1 (en) * | 2004-06-30 | 2006-01-05 | Joseph Kaspi | Process for the preparation of terbinafine and salts thereof |
| WO2006003492A2 (fr) * | 2004-07-02 | 2006-01-12 | Warner-Lambert Company Llc | Compositions et methodes de traitement d'infections pathologiques |
| US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| CN1293037C (zh) * | 2004-11-03 | 2007-01-03 | 浙江海正药业股份有限公司 | 一种制备特比萘芬盐酸盐的方法 |
| RU2274635C1 (ru) * | 2004-12-29 | 2006-04-20 | Федеральное государственное предприятие Государственный научно-исследовательский институт органической химии и технологии (ФГУП ГосНИИОХТ) | Способ получения тербинафина или его гидрохлорида |
| JP2009502258A (ja) * | 2005-07-21 | 2009-01-29 | ノミール・メディカル・テクノロジーズ・インコーポレーテッド | 標的部位の生物学的汚染物質のレベルを下げる方法 |
| WO2008073863A2 (fr) * | 2006-12-08 | 2008-06-19 | Auspex Pharmaceuticals, Inc. | Préparation et utilité d'allylamines substituées |
| US20080176908A1 (en) * | 2007-01-18 | 2008-07-24 | Mcanally Weylan R | Method of using squalene monooxygenase inhibitors to treat acne |
| US20090082469A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched terbinafine |
| MX2011000932A (es) * | 2008-07-23 | 2011-05-19 | Targeted Delivery Technologies Ltd | Metodos para administrar formulaciones antifungicas topicas para el tratamiento de infecciones fungicas. |
| EP2730271B1 (fr) | 2012-11-11 | 2018-01-24 | Symrise AG | Compositions aqueuses |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| ES2701758T3 (es) | 2013-02-27 | 2019-02-25 | Symrise Ag | Extracto de jengibre para la protección de citoblastos |
| CN105377355A (zh) | 2013-03-14 | 2016-03-02 | 拇趾公司 | 治疗甲单元的感染、疾病或病症的方法 |
| EP2862852B1 (fr) | 2013-10-18 | 2018-07-04 | Symrise AG | Derivees d'urée por la protection de cellules souches |
| ES2643590T3 (es) | 2014-03-18 | 2017-11-23 | Symrise Ag | Dióxido de titanio revestido para reducir el efecto de blanqueamiento en la piel |
| ES2819207T3 (es) | 2014-04-29 | 2021-04-15 | Symrise Ag | Mezclas activas |
| EP3045161A1 (fr) | 2015-01-18 | 2016-07-20 | Symrise AG | Compositions actives comprenant du 1,2-hexanediol et du 1,2-octanediol |
| CN104725240B (zh) * | 2015-02-12 | 2017-05-24 | 吉林修正药业新药开发有限公司 | 一种盐酸特比萘芬z型异构体的制备方法 |
| CN108084125B (zh) * | 2016-11-23 | 2020-08-18 | 华东理工大学 | 苯并杂环烷基胺类化合物及其用途 |
| US11825919B2 (en) | 2019-11-12 | 2023-11-28 | Ykk Corporation | Slide fastener |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE623609A (fr) * | 1961-10-27 | |||
| DE2716943C2 (de) * | 1976-04-28 | 1986-08-14 | Sandoz-Patent-GmbH, 7850 Lörrach | N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung |
| DE2862103D1 (en) * | 1977-08-19 | 1982-11-18 | Sandoz Ag | Propenyl amines, processes for their production and pharmaceutical compositions containing them |
-
1980
- 1980-08-06 AT AT80104623T patent/ATE10272T1/de active
- 1980-08-06 EP EP80104623A patent/EP0024587B1/fr not_active Expired
- 1980-08-06 DE DE1999175055 patent/DE19975055I1/de active Pending
- 1980-08-06 CY CY141080A patent/CY1410A/xx unknown
- 1980-08-06 DE DE8080104623T patent/DE3069633D1/de not_active Expired
- 1980-08-06 DE DE1993175084 patent/DE19375084I2/de active Active
- 1980-08-15 FI FI802583A patent/FI65775C/fi not_active IP Right Cessation
- 1980-08-19 IL IL60877A patent/IL60877A/xx unknown
- 1980-08-20 AU AU61592/80A patent/AU538928B2/en not_active Expired
- 1980-08-20 DK DK357980A patent/DK153470C/da not_active IP Right Cessation
- 1980-08-20 CA CA000358656A patent/CA1157023A/fr not_active Expired
- 1980-08-20 NZ NZ194714A patent/NZ194714A/en unknown
- 1980-08-21 PH PH24470A patent/PH22166A/en unknown
- 1980-08-21 IE IE1770/80A patent/IE50878B1/en not_active IP Right Cessation
- 1980-08-21 YU YU2096/80A patent/YU41513B/xx unknown
- 1980-08-21 JP JP11578880A patent/JPS5632440A/ja active Granted
- 1980-08-21 PT PT71717A patent/PT71717B/pt unknown
- 1980-08-21 ES ES494408A patent/ES8105694A1/es not_active Expired
- 1980-08-22 ZA ZA00805185A patent/ZA805185B/xx unknown
-
1984
- 1984-09-04 US US06/646,724 patent/US4755534A/en not_active Expired - Lifetime
-
1986
- 1986-12-30 MY MY181/86A patent/MY8600181A/xx unknown
-
1987
- 1987-10-06 KE KE3775A patent/KE3775A/xx unknown
- 1987-10-13 SG SG892/87A patent/SG89287G/en unknown
-
1988
- 1988-01-27 JP JP63016755A patent/JPS63313753A/ja active Granted
- 1988-03-24 HK HK215/88A patent/HK21588A/en not_active IP Right Cessation
-
1993
- 1993-06-30 LU LU88343C patent/LU88343I2/fr unknown
- 1993-07-02 NL NL930136C patent/NL930136I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU88343I2 (fr) | Terbinafine sous toutes les formes y compris ses seis tel que le chlorhydrate | |
| ATE9793T1 (de) | 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| GB1046506A (en) | Guanidine compounds and process for their manufacture | |
| IT1152287B (it) | Pirrolidin-derivati | |
| FI894061A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
| DK441180A (da) | 2-hydroxyalkyl-3,4,5-trihydroxypiperidiner deres fremstilling og anvendelse | |
| FI812804L (fi) | 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel | |
| IL86723A0 (en) | Guanidine-related compounds comprising a tetraphenylborate ion,their preparation and their use | |
| ATE35261T1 (de) | 4-ethyl-2-hydroxy-3-methyl-2-phenylmorpholin und dessen additionssalze. | |
| DE58906759D1 (de) | Substituierte thienylethylamine und Verfahren zu deren Herstellung. | |
| PT100104A (pt) | Processo para a preparacao de aminoalcanos substituidos | |
| ES429698A2 (es) | Procedimiento para la preparacion de bencilaminas. | |
| NL190774C (nl) | Hydrochloridezouten van een fenyl- en een carboximide-amidegroep bevattende verbindingen met een antidepressieve werking, alsmede een farmaceutisch preparaat, dat een zodanige verbinding bevat. | |
| GB1025160A (en) | Quaternary benzylammonium salts and their production | |
| GB834839A (en) | Improvements in or relating to photographic desensitising compounds and to their use |